Skip to main content
SpringerLink
Log in

Postkoitale Kontrazeption

Emergency contraception

  • CME Weiterbildung · Zertifizierte Fortbildung
  • Published:
Gynäkologische Endokrinologie Aims and scope

An Erratum to this article was published on 05 April 2012

Zusammenfassung

Bei ungeschütztem Geschlechtsverkehr kommt es bei 8 von 100 Frauen zu einer Schwangerschaft. Methoden der postkoitalen Kontrazeption zur nachträglichen Verhinderung einer Schwangerschaft nach bereits erfolgtem ungeschütztem oder nicht effektiv geschütztem Geschlechtsverkehr verringern die Schwangerschaftsrate auf <2%. Aktuell in Deutschland als Notfallkontrazeption verfügbar sind 1,5 mg Levonorgestrel in einem Intervall von bis zu 72 h und 3 mg Ulipristalacetat in einem erweiterten Zeitfenster von bis zu 120 h nach ungeschütztem Geschlechtsverkehr. Beide Präparate sind verschreibungspflichtig.

Im „off-label use“ kann nach ungeschütztem Geschlechtsverkehr die Einlage eines kupferhaltigen Intrauterinpessars zur Verhinderung der Konzeption erfolgen. Vorteilhaft ist, dass im Anschluss eine längerfristige Kontrazeption besteht.

Abstract

Unprotected or ineffectively protected sexual intercourse results in pregnancy in approximately 8 out of 100 women. Methods of postcoital contraception for subsequent avoidance of pregnancy reduce the conception rate to less than 2 out of 100. Modern currently available methods of emergency postcoital contraception in Germany are single dose 1.5 mg levonorgestrel up to 72 h and 3 mg ulipristal acetate in an extended interval up to 120 h after unprotected sexual intercourse. Both medications are only available by prescription. The insertion of a copper-containing intrauterine pessary is an alternative method to prevent pregnancy in off-label use, with the benefit of ongoing, long-term contraception.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Trussell J, Rodriguez G, Ellertson C (1999) Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception 59:147–151

    Article  CAS  PubMed  Google Scholar 

  2. Benson Gold R (2005) The Implications of defining when a woman is pregnant. Guttmacher Rep Public Policy 8:7–10. http://www.guttmacher.org/pubs/tgr/08/2/gr080207.pdf

    Google Scholar 

  3. Bundeszentrale für gesundheitliche Aufklärung (Hrsg) (2011) Verhütungsverhalten Erwachsener 2011. Aktuelle repräsentative Studie im Rahmen einer Mehrthemenbefragung. http://www.sexualaufklaerung.de/cgi-sub/fetch.php?id=701

  4. Cooper TG, Yeung CH (2006) Computer-aided evaluation of assessment of grade A spermatozoa by experienced technicians. Fertil Steril 85:220–224

    Article  PubMed  Google Scholar 

  5. Demers LM (1971) The morning-after pill. N Engl J Med 284:1034–1036

    Google Scholar 

  6. Haspels AA (1976) Interception: post-coital estrogens in 3016 women. Contraception 14:375–381

    Article  CAS  PubMed  Google Scholar 

  7. Herbst AL, Ulfelder H, Poskanzer DC (1971) Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284:878–881

    Google Scholar 

  8. Yuzpe A, Thurlow H, Ramzy I et al (1974) Postcoital contraception – a pilot study. J Reprod Med 13:53–58

    CAS  PubMed  Google Scholar 

  9. Grimes DA, Raymond EG (2002) WHO-Empfehlungen. http://www.who.int/mediacentre/factsheets/fs244/en/

  10. Trussell J, Rodriguez G, Ellertson C (1999) Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception 59:147–151

    Article  CAS  PubMed  Google Scholar 

  11. Johnson JH (1984) Contraception – the morning after. Fam Plan Perspect 16:266–270

    Article  CAS  Google Scholar 

  12. American College of Obstetricians and Gynecologists (2010) ACOG practice bulletin. Emergency contraception. Number 112, December 2010. Gynecol Obstet 115:1–10

    Article  Google Scholar 

  13. Vasilakis C, Jick SS, Jick H (1999) The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception 59:79–83

    Article  CAS  PubMed  Google Scholar 

  14. Brent RL (2004) Environmental causes of human congenital malformations: the pediatrician’s role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics 113(Suppl 4):957–968

    PubMed  Google Scholar 

  15. Glasier A (1997) Emergency postcoital contraception. N Engl J Med 337:1058–1064

    Google Scholar 

  16. Marions L, Hultenby K, Lindell I et al (2002) Emergency contraception with mifepristone and levonorgestrel: mechanism of action. Obstet Gynecol 100:65–71

    Article  CAS  PubMed  Google Scholar 

  17. Lalitkumar PG, Lalitkumar S, Meng CX et al (2007) Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model. Hum Reprod 22:3031–3037

    Article  CAS  PubMed  Google Scholar 

  18. Cleland K, Raymond E, Trussell J et al (2010) Ectopic pregnancy and emergency contraceptive pills: a systematic review. Obstet Gynecol 115:1263–1266

    Article  PubMed  Google Scholar 

  19. Bastianelli C, Farris M (2011) Emergency contraception. Presently available formulations and controversies surrounding their use. Expert Rev Obstet Gynecol 6:569–576

    Article  Google Scholar 

  20. Hertzen H von, Piaggio G, Ding J et al (2002) Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial. Lancet 360:1803–1810

    Article  Google Scholar 

  21. Piaggio G, Hertzen H von, Grimes DA, Look PF van (1999) Timing of emergency contraception with levonorgestrel or the Yuzpe regimen. Task force on postovulatory methods of fertility regulation. Lancet 353:721

    Article  CAS  PubMed  Google Scholar 

  22. Fine P, Matte H, Ginde Cullins V et al (2010) Ulipristal acetate taken 48–120 hours after intercourse for emergency contraception. Obstet Gynecol 115:257–263

    Article  PubMed  Google Scholar 

  23. Glasier A, Cameron S, Fine P et al (2010) Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analisis. Lancet 375:555–562

    Article  CAS  PubMed  Google Scholar 

  24. Stratton P, Levens ED, Hartog B et al (2010) Endometrial effects of a single early luteal dose of the selective progesterone receptor modulator CDB-2914. Fertil Steril 93:2035–2041

    Article  CAS  PubMed  Google Scholar 

  25. Haspels AA (1988) Post-coital contraception. IPPF Med Bull 22:1–3

    CAS  PubMed  Google Scholar 

  26. Trussell J, Rodriguez G, Ellerson C (1999) Updated estimates of the effectiveness of the Yuzpe regimen of emergency contraception. Contraception 59:147–151

    Article  CAS  PubMed  Google Scholar 

  27. Weaver MA, Raymond EG, Baecher L (2009) Attitude and behavior effects in a randomized trial of increased access to emergency contraception. Obstet Gynecol 113:107–116

    PubMed  Google Scholar 

  28. Glasier A, Cameron ST, Blithe D et al (2011) Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 84:363–367

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt

Keine Angabe

Author information

Authors and Affiliations

  1. Abteilung für Gynäkologische Endokrinologie und Fertilitätsstörungen, Universitätsfrauenklinik Heidelberg, Voßstr. 9, 69115, Heidelberg, Deutschland

    M. Goeckenjan, T. Rabe & T. Strowitzki

Authors
  1. M. Goeckenjan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Rabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Strowitzki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Goeckenjan.

Additional information

Ein Erratum zu diesem Beitrag ist unter http://dx.doi.org/10.1007/s10304-012-0492-8 zu finden.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goeckenjan, M., Rabe, T. & Strowitzki, T. Postkoitale Kontrazeption. Gynäkologische Endokrinologie 10, 45–56 (2012). https://doi.org/10.1007/s10304-011-0463-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10304-011-0463-5

Schlüsselwörter

Keywords

Search

Navigation